An interventional study of PRF stimulation and Sham stimulation in Carpal Tunnel Syndrome, sponsored by GiMer Medical. Completed at 5 sites in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2023-02-27.
Sponsored by GiMer Medical · Not applicable, Interventional, and Treatment
Among 39 studies in Carpal Tunnel Syndrome with a site in Taiwan — 5 open to participants now, 5 under way, none of them phase 3. Carpal Tunnel Syndrome · Taiwan.
Among the 39 studies in Carpal Tunnel Syndrome with a site in Taiwan, this one is the 17th largest by enrollment of the 38 interventional ones that give a count, is the only one that started in 2022, is one of 38 with no phase, and was the 34th registered.
589 studies on the registry are indexed under Carpal Tunnel Syndrome; 134 are open to participants now.
Browse Carpal Tunnel Syndrome studies →5 of the 39 studies in Carpal Tunnel Syndrome with a site in Taiwan are open now. Recruiting first, the newest first:
Shin Kong Wu Ho-Su Memorial Hospital · Sites in Taiwan
Ages 20–80
China Medical University Hospital · Sites in Taiwan
Ages 20–85 · Healthy volunteers
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation · Sites in Taiwan
Ages 20–80
National Cheng-Kung University Hospital · Sites in Taiwan
Ages 20–80
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 20–75
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 73 Carpal Tunnel Syndrome studies recruiting now, 27 (37%) set no upper age limit and 37 (51%) stop at 75 or younger; 1 takes children under 18; 10 take healthy volunteers.
This study: 20 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
39 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 1 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 58 is close to the median of 60 across 444 interventional studies indexed under Carpal Tunnel Syndrome.
Median enrollment 54 across the 38 interventional studies, 126 across the 1 observational. Of the 25 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 39 have an industry lead sponsor. The 10 most frequent:
GiMer Medical is the lead sponsor of 4 studies on the registry; none are open to participants now.
GiMer Medical has 1 study filed under Carpal Tunnel Syndrome — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 39 studies in Carpal Tunnel Syndrome with a site in Taiwan, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The objective of this study is to assess the efficacy and safety of Carpal Stim for pain relief in CTS subjects.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Clinical diagnosis of CTS：
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Subject receiving fake stimulation (no stimulation but same device procedure with PRF group)
Device: Sham stimulation
Subject receiving 500 KHz PRF stimulation for 15 min
Device: PRF stimulation
One time 500 kHZ stimulation for 15 min
Sham stimulation for 15 min
Effectiveness: The responder rate of the PRF group and Sham-Control group
Time frame: 1 hour after end of stimulation
Safety: Incidence of adverse events (AEs) and serious AEs (SAEs)
Time frame: Up to 14 days
Safety: Change in Nerve Conduction Velocity 14th day compared to baseline
Median nerve sensory latency time change over 20%
Time frame: 14 days
Proportion in responder in treatment and sham-controlled groups
Time frame: 3, 7, 14 days after end of stimulation
Change in NRS score in treatment and sham-controlled groups compared to baseline
Time frame: 1hr, 3, 7, 14 days after end of stimulation
Change in PGIC scale in treatment and sham-controlled compared to baseline
Time frame: 1hr, 3, 7, 14 days after end of stimulation
Change in GSS score in treatment and sham-controlled compared to baseline
Time frame: 1hr, 3, 7, 14 days after end of stimulation
Change in BCTQ-SSS score in treatment and sham-controlled compared to baseline
Time frame: 14 days after end of stimulation
Change in BCTQ-FSS score in treatment and sham-controlled compared to baseline
Time frame: 14 days after end of stimulation
Plan to share: No
No publications or documents are linked to this record.
Ran from Mar 2022 to primary completion in Dec 2022, 9 months.
Of 261 interventional studies with no phase under Carpal Tunnel Syndrome, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 26. This study's 9 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
GiMer Medical